Patient info

Clarithromycin 250 mg film-coated tablets – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
250 mg
Contains active substance:

Patient leaflet - Clarithromycin 250 mg film-coated tablets

1. What Clarithromycin Tablet is and what it is used for

Each clarithromycin tablet contains 250 mg or 500 mg of the active ingredient clarithromycin.

Clarithromycin belongs to a group of medicines called macrolide antibiotics.

Antibiotics stop the growth of bacteria (bugs) which cause infections. Clarithromycin tablets are used to treat infections such as:

  1. 1. Chest infections such as bronchitis and pneumonia
  2. 2. Throat and sinus infections
  3. 3. Skin and tissue infections
  4. 4.

    Helicobacter pylori infection associated with

    duodenal ulcer

Clarithromycin tablets are indicated in adults and children 12 years and older.

2. What you need to know before you take clarithromycin Tablets

Do not take clarithromycin Tablets if you;

  • know that you are allergic to clarithromycin, other

    macrolide antibiotics such as erythromycin or azithro-mycin, or any of the other ingredients in the tablets.

  • are taking medicines called ergotamine or dihydroergot-

    amine tablets or use ergotamine inhalers for migraine.

  • are taking medicines called terfenadine or astemizole

    (widely taken for hay fever or allergies) or cisapride (for stomach disorders) or pimozide (for mental health problems) as combining these drugs can sometimes cause serious disturbances in heart rhythm. Consult your doctor for advice on alternative medicines.

  • are taking other medicines which are known to cause

    serious disturbances in heart rhythm.

  • are taking lovastatin or simvastatin (HMG-CoA

    reductase inhibitors, commonly known as statins, used to lower levels of cholesterol (a type of fat) in the blood).

  • are taking oral midazolam (a sedative).
  • have severe liver disease with kidney disease.
  • or someone in your family has a history of heart rhythm

    disorders (ventricular cardia arrhythmia, including torsades de pointes) or abnormality of electrocardiogram (ECG, electrical recording of the heart) called “long QT syndrome”.

  • are taking medicines called ticagrelor or ranolazine (for

    heart attack, chest pain or angina).

  • are taking colchicine (usually taken for gout).
  • are taking a medicine containing lomitapide
  • have abnormally low levels of potassium or magnesium

    in your blood (hypokalaemia or hypomagnesaemia) Warnings and precautions

Talk to your doctor or pharmacist before taking clarithromycin tablets;

  • if you have heart problems (e.g. heart disease, heart

    failure, an unusually slow heart rate)

  • if you have any liver or kidney problems
  • if you have, or are prone to, fungal infections (e.g. thrush)
  • if you are pregnant or breast feeding

Children

Clarithromycin tablets are not suitable for use in children under 12 years of age.

Other medicines and Clarithromycin Tablets

You should not take clarithromycin tablets if you are taking any of the medicines listed in the section above “Do not take clarithromycin tablets if you;”

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines as your dose may need to be changed or you may need to have regular test performed:

  • digoxin, quinidine or disopyramide (for heart problems)
  • ibrutinib (for cancer treatment)
  • warfarin, or any other anticoagulant e.g. dabigatran,

    rivaroxaban, apixaban (for thinning the blood)

  • carbamazepine, valproate, phenobarbital or phenytoin

    (for epilepsy)

  • atorvastatin, rosuvastatin (HMG-CoA reductase

    inhibitors, commonly known as statins and used to lower levels of cholesterol (a type of fat) in the blood).

    Statins can cause rhabdomyolosis (a condition which causes the breakdown of muscle tissue which can result in kidney damage) and signs of myopathy (Muscle pain or muscle weakness) should be monitored.

    • nateglinide, pioglitazone, repaglinide, rosiglitazone or insulin (used to lower blood glucose levels)
    • gliclazide or glimepiride (sulphonylureas used in the treatment of type II diabetes)
    • theophylline (used in patients with breathing difficulties such as asthma)
    • triazolam, alprazolam or intravenous or oromucosal midazolam (sedatives)
    • cilostazol (for poor circulation)
    • methylprednisolone (a corticosteroid) given by mouth, by injection or inhaled (used to help suppress the body's immune system - this is useful in treating a wide range of conditions)
    • vinblastine (for treatment of cancer)
    • ciclosporin, sirolimus and tacrolimus (immune suppressants)
    • methadone (used in the treatment of opioid addiction)
    • etravirine, efavirenz, nevirapine, ritonavir, zidovudine, atazanavir, saquinavir (anti- viral drugs used in the treatment of HIV)
    • rifabutin, rifampicin, rifapentine, fluconazole, itraconazole

      (used in the treatment of certain bacterial infections)

    • tolterodine (for overactive bladder)
    • verapamil, amlodipine, diltiazem (for high blood pressure)
    • sildenafil, vardenafil and tadalafil (for impotence in adult males or for use in pulmonary arterial hypertension (high blood pressure in the blood vessels of the lung)
    • St John’s Wort (a herbal product used to treat depression)
    • quetiapine or other antipsychotic medicines.
    • other macrolide medicines
    • lincomycin and clindamycin (lincosamides – a type of antibiotic)
    • Hydroxychloroquine or chloroquine (used to treat conditions including rheumatoid arthritis, or to treat or prevent malaria). Taking these medicines at the same time as clarithromycin may increase the chance of you getting side effects that affect your heart.

Please tell your doctor if you are taking oral contraceptive pills and diarrhoea or vomiting occurs, as you may need to take extra contraceptive precautions such as using a condom. Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist before taking this medicine as the safety of clarithromycin tablets in pregnancy and breast-feeding is not known.

Driving and using machines

Clarithromycin tablets may make you feel dizzy or drowsy. If they affect you in this way do not drive, operate machinery or do anything that requires you to be alert.

Clarithromycin Tablets contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.

3. How to take Clarithromycin Tablets

Do not give these tablets to children under 12 years. Your doctor will prescribe another suitable medicine for your child. Always take Clarithromycin tablets exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Clarithromycin may be given with or without food. The recommended dose is;

For chest infections, throat or sinus infections and skin and soft tissue infections:

Usual dose of clarithromycin tablets for adults and children over 12 years is 250 mg twice daily for 6 to 14 days, e.g. one 250 mg tablet in the morning and one in the early evening. Your doctor may increase the dose to 500 mg twice daily in severe infections.

Clarithromycin tablets should be swallowed with at least half a glass of water.

For the treatment of Helicobacter pylori infection associ-ated with duodenal ulcers:

There are a number of effective treatment combinations available to treat Helicobacter pylori in which clarithromycin tablets are taken together with one or two other drugs. These combinations include the following and are usually taken for 6 to 14 days:

  1. a) One Clarithromycin 500 mg tablet taken twice a day together with amoxycillin, 1000 mg taken twice a day plus lansoprazole, 30 mg twice a day.
  2. b) One Clarithromycin 500 mg tablet taken twice a day together with metronidazole, 400 mg taken twice a day plus lansoprazole, 30 mg twice a day.
  3. c) One Clarithromycin 500 mg tablet taken twice a day together with amoxycillin, 1000 mg taken twice a day or metronidazole, 400 mg taken twice a day plus omeprazole, 40 mg a day.
  4. d)

    One Clarithromycin 500 mg tablet taken twice a day together with amoxycillin, 1000 mg taken twice a day plus omeprazole, 20 mg taken once a day.

    The treatment combination that you receive may differ slightly from the above. Your doctor will decide which treatment combination is the most suitable for you. If you are unsure which tablets you should be taking or how long you should be taking them for, please consult your doctor for advice.

If you take more Clarithromycin tablets than you should

If you accidentally take more clarithromycin tablets in one day than your doctor has told you to, or if a child accidentally swallows some tablets, contact your doctor or nearest hospital emergency department immediately. An overdose of clarithromycin tablets is likely to cause vomiting and stomach pains.

If you forget to take Clarithromycin tablets

If you forget to take a clarithromycin tablet, take one as soon as you remember. Do not take more tablets in one day than your doctor has told you to.

If you stop taking Clarithromycin tablets

Do not stop taking clarithromycin tablets, even if you feel better. It is important to take the tablets for as long as the doctor has told you to, otherwise the problem might come back. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, clarithromycin tablets can cause side effects although not everybody gets them.

If you suffer from any of the following at any time during your treatment STOP TAKING your tablets and contact your doctor immediately:

  • severe or prolonged diarrhoea, which may have blood

    or mucus in it. Diarrhoea may occur over two months after treatment with clarithromycin, in which case you should still contact your doctor.

  • a rash, difficulty breathing, fainting or swelling of the

    face, tongue, lips, eyes and throat. This is a sign that you may have developed an allergic reaction.

  • yellowing of the skin (jaundice), skin irritation, pale stools,

    dark urine, tender abdomen or loss of appetite. These may be signs that your liver may have inflammation and not be working properly.

  • severe skin reactions such as painful blistering of the

    skin, mouth, lips, eyes and genitals (symptoms of a rare allergic reaction called Stevens-Johnson syndrome/tox-ic epidermal necrolysis).

  • a red, scaly rash with bumps under the skin and blisters

    (symptoms of exanthematous pustulosis). The frequen-cy of this side effect is not known (cannot be estimated from the available data).

  • rare allergic skin reactions which cause severe illness

    with ulceration of the mouth, lips and skin which causes severe illness with rash, fever and inflammation of internal organs (DRESS).

  • muscle pain or weakness known as rhabdomyolysis (a

    condition which causes the breakdown of muscle tissue which can result in kidney damage).

Other side effects

Common side effects of (may affect up to 1 in 10 people) include;

  • difficulty sleeping
  • changes in sense of taste
  • headache
  • widening of blood vessels
  • stomach problems such as feeling sick, vomiting,

    stomach pain, indigestion, diarrhoea

  • increased sweating

Uncommon side effects (may include up to 1 in 100 people) include:

  • high temperature
  • swelling, redness or itchiness of the skin, oral or vaginal

    ‘thrush’ (a fungal infection)

  • inflammation of the stomach and intestines
  • decrease in the level of blood platelets (blood platelets

    help stop bleeding)

  • decrease in white blood cells (leukopenia)
  • decrease in neutrophils (neutropenia)
  • stiffness
  • chills
  • increase of eosinophils (white blood cells involved in

    immunity)

  • exaggerated immune response to a foreign agent
  • lack or loss of appetite
  • anxiety, nervousness
  • drowsiness, tiredness, dizziness or shaking
  • involuntary muscle movements
  • vertigo
  • ringing in the ears or hearing loss
  • chest pain or changes in heart rhythm such as palpita-

    tions or an irregular heartbeat

  • asthma: lung disease associated with tightening of air

    passages, making breathing difficult

  • nose bleed
  • blood clot that causes sudden blockage in a lung artery

    (pulmonary embolism)

  • inflammation of the lining of the gullet (oesophagus) and

    lining of the stomach

  • anal pain
  • bloating, constipation, wind, burping
  • dry mouth
  • situation where the bile (fluid made by the liver and stored

    in the gallbladder) cannot flow from the gallbladder to the duodenum (cholestasis)

  • inflammation of the skin characterized by the presence of

    the bullae which are filled with fluid, itchy and painful rash

  • muscle spasms, muscle pain or loss of muscle tissue. If

    you suffer from myasthenia gravis (a condition in which the muscles become weak and tire easily), clarithromy-cin may worsen these symptoms

    • raised abnormal kidney and liver function blood test and raised blood tests
    • feeling weak, tired and having no energy

Not known side effects (frequency cannot be estimated from the available data):

  • inflammation of the colon
  • bacterial infection of the outer layers of the skin
  • reduction in the level of certain blood cells (which can make infections more likely or increase the risk of bruising or bleeding)
  • confusion, loss of bearings, hallucinations (seeing things), change in sense of reality or panicking, depres-sion, abnormal dreams or nightmares and mania (feeling of elation or over-excitement)
  • convulsions (fits)
  • paraesthesia, more commonly known as ‘pins and needles’
  • loss of taste or smell or inability to smell properly
  • type of heart rhythm disorder (Torsade de pointes, ventricular tachycardia)
  • loss of blood (haemorrhage)
  • inflammation of the pancreas
  • discolouration of the tongue or teeth
  • acne
  • change in the levels of products produced by the kidney, inflammation of the kidney or an inability of the kidney to function properly (you may notice tiredness, swelling or puffiness in the face, abdomen, thighs or ankles or problems with urination)

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Clarithromycin Tablets

Keep this medicine out of the sight and reach of children Do not use these tablets after the expiry date that which is stated on the carton and blister. The expiry date refers to the last day of that month.

This medicinal product does not require any special storage condition.

Do not throw away any medicines via wastewater or household water. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information What clarithromycin Tablets contain

Each clarithromycin 250 mg and 500 mg film-coated tablet contain clarithromycin as active ingredient.

Core ingredients: cellulose microcrystalline, croscarmellose sodium, povidone, colloidal anhydrous silica, stearic acid, talc, magnesium stearate.

Coating Ingredients: Hypromellose, hydroxypropyl cellulose, titanium dioxide, propylene glycol, sorbitan monooleate, talc, sorbic acid and vanillin.

What clarithromycin Tablets looks like and contents of the pack

250 mg: White capsule shaped, film coated tablets embossed with 'C1' on one side and plain on other side. 500 mg: White capsule shaped, film coated tablets embossed with 'C2' on one side and plain on other side. Blister pack of Alu/PVC/PVDC containing 7, 14 and 21 tablets. HDPE bottle packs of 500’s and 1000’s tablets Not all pack sizes may be marketed.

Marketing Authorisation Holder:

Rudipharm Limited

Unit 6, Salbrook Road Industrial Estate

Salbrook Road, Redhill, Surrey, RH1 5GJ, UK

Manufacturer:

Rudipharm Limited

Oak House, Reeds Crescent,

Watford, WD24 4QP, UK

To listen to or request a copy of this leaflet in Braille, large print or audio please call, 01293 827819 (UK only)

Please be ready to give the following information: Product name Reference number Clarithromycin 250mg PL 49565/0029 Film-coated Tablets

Clarithromycin 500mg PL 49565/0030 Film-coated Tablets

POM

This leaflet was last revised in February 2026.

Normal Text: 7pt (Roman)

Clarithromycin 250/500 mg Tablets - PIL Dimension: 150 x 285 mm

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 49565/0029

Last revision stated in the text: February 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Clarithromycin 250 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Clarithromycin
Strength 250 mg
Pharmaceutical form Oral tablet
White, oblong, biconvex film-coated tablets with ‘K’ and ‘250’ debossed on one side and plain on the other side.
How is it taken Oral
Excipients Croscarmellose sodium, Microcrystalline Cellulose (E 460), Colloidal anhydrous silica, Powdered cellulose (E 460), Magnesium stearate, Hypromellose (E 464), Titanium dioxide (E 171), Macrogol, Lactose monohydrate
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 36 Months
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC) Antibacterial for systemic use, macrolide ATC-Code: J01FA09
  1. J Antiinfectives for systemic use
    1. J01 Antibacterials for systemic use
      1. J01F Macrolides, lincosamides and streptogramins
        1. J01FA Macrolides
          1. J01FA09 clarithromycin
Marketing authorisation PL 17907/0690 (first authorised 2 August 2023), PL 49565/0029 (first authorised 5 February 2024)
Marketing authorisation holder Bristol Laboratories Limited, Rudipharm Limited
Codes BNF 05010500

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.